Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Chinese Patent Office
Cerilliant
AstraZeneca
Harvard Business School
Teva
McKinsey
Chubb

Generated: December 18, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Eagle Pharms

« Back to Dashboard

Eagle Pharms Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Eagle Pharms bendamustine hydrochloride 205580 100MG INJECTABLE; INJECTION
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Argus Health
Colorcon
Fish and Richardson
Harvard Business School
UBS
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.